Tanaka Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,923
Closed -$191K 52
2019
Q3
$191K Sell
1,923
-192
-9% -$18.2K 0.62% 29
2019
Q2
$196K Sell
2,115
-1,626
-43% -$154K 0.6% 30
2019
Q1
$353K Sell
3,741
-449
-11% -$39.3K 1.06% 28
2018
Q4
$269K Hold
4,190
0.86% 27
2018
Q3
$375K Sell
4,190
-2,896
-41% -$256K 0.87% 29
2018
Q2
$563K Sell
7,086
-66
-0.9% -$5.48K 1.35% 22
2018
Q1
$638K Buy
7,152
+65
+0.9% +$6.24K 1.53% 19
2017
Q4
$740K Sell
7,087
-7,018
-50% -$792K 1.69% 20
2017
Q3
$2.06M Buy
14,105
+160
+1% +$21.8K 4.59% 7
2017
Q2
$1.81M Sell
13,945
-37
-0.3% -$4.53K 4.15% 7
2017
Q1
$1.74M Sell
13,982
-235
-2% -$28.1K 3.84% 10
2016
Q4
$1.65M Buy
14,217
+12
+0.1% +$1.34K 3.85% 10
2016
Q3
$1.49M Sell
14,205
-30
-0.2% -$3.25K 3.56% 7
2016
Q2
$1.4M Sell
14,235
-55
-0.4% -$5.69K 3.61% 7
2016
Q1
$1.43M Sell
14,290
-6,925
-33% -$713K 3.22% 8
2015
Q4
$2.54M Buy
21,215
+7,030
+50% +$813K 5.47% 4
2015
Q3
$1.53M Buy
14,185
+6,597
+87% +$819K 3.88% 7
2015
Q2
$878K Hold
7,588
2.18% 14
2015
Q1
$875K Buy
7,588
+22
+0.3% +$2.63K 2.42% 11
2014
Q4
$846K Sell
7,566
-80
-1% -$8.44K 2.52% 12
2014
Q3
$722K Hold
7,646
2.1% 17
2014
Q2
$657K Buy
7,646
+24
+0.3% +$1.82K 1.74% 18
2014
Q1
$532K Buy
+7,622
New +$604K 1.62% 22

Other funds holding CELG

Tanaka Capital Management's CELG Position: Q4 2019 in Review

Tanaka Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,923 shares — an estimated $191K sold.

Tanaka Capital Management first reported a position in CELG in Q1 2014 and held it in 23 quarters. The position peaked at $2.54M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Tanaka Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Tanaka Capital Management sold 1,923 Celgene Corp shares in Q4 2019, an estimated $191K.
  • Tanaka Capital Management first reported a position in Celgene Corp in Q1 2014 and held it in 23 quarters.
  • Tanaka Capital Management's Celgene Corp position peaked at $2.54M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Tanaka Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.